Prevention study for women with a BRCA1 or BRCA2 mutation who are scheduled for risk-reducing salpingo-oophorectomy
Clinicaltrials.gov identifier:NCT04794322
Developing a Test for the Detection of Ovarian Cancer
Prevention study for women with a BRCA1 or BRCA2 mutation who are scheduled for risk-reducing salpingo-oophorectomy
Clinicaltrials.gov identifier:NCT04794322
About the Study
NOTE: This study is no longer recruiting patients.
The purpose of this study is to develop a test for early detection of ovarian cancer. Two patient populations are included in this study: women scheduled for surgery or testing for suspected but undiagnosed ovarian/fallopian tube cancer, and women with a or mutation who are scheduled for a risk-reducing salpingo-oophorectomy.
This Study is Open To:
NOTE: This study is no longer recruiting patients.
This Study is NOT Open To:
NOTE: This study is no longer recruiting patients.
Locations:
Arkansas
City: Little Rock RECRUITING
Facility: University of Arkansas for Medical Sciences
Contact Info:
BScanlan@uams.edu
501-686-8274
Kristin Zorn, MD
Maryland
City: Annapolis RECRUITING
Facility: Anne Arundel Health System
Contact Info:
jmiller9@aahs.org
443-481-5738
Monica Jones, MD
City: Baltimore RECRUITING
Facility: Johns Hopkins University School of Medicine
Contact Info:
rstone15@jhmi.edu
Rebecca Stone, MD
Washington
City: Seattle RECRUITING
Facility: The Swedish Hospital
Contact Info:
rpearhil@fredhutch.org
206-667-3278
Charles Drescher, MD